Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CM and UC-MSCs for Acute Ischemic Stroke
NCT05008588Phase 2Active, not recruiting
- Sponsor
- Prodia Stem Cell Indonesia
- Start
- May 2022
- Primary completion
- Mar 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in ischemic stroke, sponsored by Prodia Stem Cell Indonesia. Started May 2022; status: active, not recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05008588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05008588.